三诺生物: 关于向控股子公司提供财务资助的进展公告

Financial Assistance Overview - The company approved a financial assistance of up to 500 million RMB to its subsidiary, Changsha Xinnuo Health Industry Investment Co., Ltd., to meet its funding needs and reduce overall financing costs [1][2] - The financial assistance will be provided for a period of three years starting from the date of approval by the 2023 annual general meeting [1][3] Financial Assistance Progress - On June 16, 2025, the company signed a loan agreement with Changsha Xinnuo Health for 9 million RMB, with a guarantee provided by Mr. Li Shaobo, a shareholder of the subsidiary [2][3] - The loan interest will be calculated based on the actual loan amount at the same rate as similar business bank loans [3][4] Risk Control Measures - The company has implemented risk control measures, including monitoring the use of funds and ensuring that the financial assistance does not exceed the approved limits [4][5] - Mr. Li Shaobo has provided a guarantee for the loan, and the company will charge a usage fee based on the actual loan amount and time, not less than the bank loan rate [5] Cumulative Financial Assistance Amount - As of the announcement date, the total financial assistance provided to Changsha Xinnuo Health amounts to 395 million RMB, representing 11.76% of the company's audited net assets for 2024 [5][6] - After this assistance, the remaining balance of financial assistance provided by the company is 105 million RMB [5]